SRNE is up +11.69% in the last 5 days.
As of 09:58 SRNE is at 4.25 -0.01 -0.23%
Sorrento Therapeutics (SRNE)
http://investorshangout.com/Sorrento-Therapeu...RNE-67124/
FDA Decision: A Big Win for Reynolds American Boy, am I seeing a shift in the winds. The FDA's green light for VELO nicotine pouches adds a fresh feather to Reynolds American's cap. In a gritty industry like tobacco, getting FDA's nod ain't just about safety; it’s a strategic leg up against traditional smoke. My gut tells me this isn't just about keeping pace. It's...
Continue Reading
Shareholders Fret Over Maplebear's Proposed Transaction It ain't every day a deal's got shareholders fidgeting more than a cat in a dog park, but here we are. Maplebear Inc. (NASDAQ: CART) finds itself under the magnifying glass as the seasoned crew over at Monteverde & Associates PC sound the alarm bells. The firm, sitting cozy in the Empire State Building, is on the...
Continue Reading
Okta Leaps to S&P 500: A Power Play You blink for a second, and boom, Okta's sitting at the big kids' table—the S&P 500. You know how rare that move is? It’s like snagging an invite to the party everyone wants to attend. Swapping out Kenvue Inc. (NYSE: KVUE), which Kimberly-Clark (NASD: KMB) is scooping up, Okta's maneuver signifies a hefty endorsement of its growth...
Continue Reading
Data Breach Fallout Looms Over Del Monte Here's the scoop on Del Monte Foods facing what looks like a data breach debacle of epic proportions. Ransomware has hit the fan, and now folks are scrambling as Edelson Lechtzin LLP gears up to lay down some serious class action heat. From Cyber Shadows to Court Considerations This storm brewed on February 7, 2026. Del Monte’s...
Continue Reading
Millrose Properties: A Storm's Brewing Whoa, step back and take a wide-eyed look at Millrose Properties—there’s a storm brewin’ and it’s a doozy! Right now, they’re up against one mighty class action lawsuit, and investors who’ve been hit for over $100k better circle December 8, 2026, on their calendars if they fancy a shot at lead plaintiff glory. We’re...
Continue Reading
Reddit's Big Gamble: A Risky Shift Investors, grab your coffee, because Reddit (NYSE: RDDT) just gave us a real eyebrow-raiser, and no one's got a clue how deep this rabbit hole goes. They pulled the curtains back and went for a logged-in-only format, and the stock took a nosedive—a good 28% drop, just like that. If you've got a vested interest here, this is your cue to...
Continue Reading
Diving into Trust: ANSI's 2027 Paper Challenge Out from the buzz of New York, the American National Standards Institute (ANSI) has stirred up some real brain-teasing talk for students across the country. Kicking off the 2027 Student Paper Competition, they're handing students a chance to ponder a question we take for granted every day. Do we ever truly consider what makes...
Continue Reading
Midwest union pride is surging again, this time with the launch of the tenth season of Built To Last® on Halloween Day. It’s like they chose this date to remind us that these builders are the spine of infrastructure we take for granted—spooky how easy it is to overlook their contributions. Spotlighting Union Excellence This isn't just another construction show;...
Continue Reading
Wrapping Up a Half-Decay of Environmental Commitment PG&E has been playing the long game with its environmental initiatives, and this wraps up a five-year saga that's worth dissecting. The PG&E Corporation Foundation has doled out its final set of grants, making a 25-strong lineup of eco-friendly campaigns. We're talking $500,000 split among five organizations trying to...
Continue Reading
Riding the Revenue Wave Now we're talking about a bank knowing their business—InsCorp, Inc. recently flaunted a 12% year-on-year revenue bump for 3Q26, a testament to a strategy that's clearly sticking. Still, while those numbers are nice and shiny, the detailed breakdown shows earnings per share (EPS) barely budged from last quarter, coming in at $0.73, just a hair...
Continue Reading
Single-Use Biopharmaceutical Market Trends The biopharmaceutical industry is witnessing significant changes, with the single-use technologies market projected to grow dramatically in the coming years. Recent estimates suggest a transition from a valued $6.5 billion in 2024 to an anticipated $11.2 billion by 2029, showcasing a healthy compound annual growth rate (CAGR) of...
Continue Reading
Continuous Composites Secures Additional Funding for Innovation Continuous Composites (CCI) has made remarkable progress in the field of high-performance materials, securing significant multi-million-dollar funding from the U.S. Air Force. This funding, awarded through a multi-year contract, aims to advance the development of innovative materials utilizing CCI's...
Continue Reading
Data Breach: Pillsbury's Alarm and Action Right off the bat, let's not mince words: data breaches are like unexpected guests that leave a mess you didn't ask for. Pillsbury Winthrop Shaw Pittman LLP, a heavyweight in the legal sector, found itself fending off a particularly sly variety of intrusion last year. Despite swift action to block these social engineering...
Continue Reading
Exciting Updates from Bayport Management Ltd Bayport Management Ltd, a prominent player in the finance sector, is making headlines with its latest communication to noteholders. They have officially notified these stakeholders about the outcomes from the recent written procedure regarding their Senior Secured Floating Rate Social Notes, commonly known as the "Notes". What...
Continue Reading
First Command Financial Services Inc. made a bold move back in 2024 by bringing John Woerner onto its board of directors. This isn't just a random hire; it’s a strategic step aimed at solidifying the firm's promise of top-tier financial guidance for military families. In a sector where trust is currency, this addition signals serious intent. John Woerner's Impressive...
Continue Reading